Clinical Trial Update: Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether GM1 prevents taxane-induced neurotoxicity in operable breast cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• GM1 (monosialotetrahexosyl ganglioside)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED